Randomised trial of mesterolone versus vitamin C for male infertility. Scottish Infertility Group.
A prospective randomised trial was carried out to assess the effect of 9 months' treatment with either mesterolone or vitamin C in 368 men complaining of an infertile marriage. There was no significant difference in the wife's pregnancy rate between the two treatment groups. A separate analysis of the data was made to include only men with a low normal testosterone (less than 16 nmol/l) and low sperm density (less than 10 million/ml). This separate analysis was also restricted to men married to wives with normal test results for tubal patency and ovulation and again there was no difference in pregnancy rates between the two treatment groups. These results indicate that mesterolone therapy given in the absence of any defined endocrinopathy is of no benefit in promoting male fertility and furthermore we have been unable to find any subgroup who will respond. Improvements in the therapy of male infertility are only likely after a diagnosis has been defined.
D001205:Ascorbic Acid / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D013196:Dihydrotestosterone / Q000031:analogs & derivatives*; D006801:Humans; D007248:Infertility, Male / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008655:Mesterolone / Q000627:therapeutic use*; D011897:Random Allocation; D013076:Sperm Count; D013739:Testosterone / Q000097:blood
D013196:Dihydrotestosterone; D008655:Mesterolone; D013739:Testosterone; D001205:Ascorbic Acid